Producers can now isolate the two key chemical compounds present in marijuana: THC (Tetrahydrocannabinol) and CBD (Cannabidiol), thanks to modern science.
FREMONT, CA: Cannabis, which has long been used for medicinal and therapeutic purposes, is now a hot commodity in food technology and other consumer goods. Cannabis, in its different forms, has been used medically throughout history and in modern times to relieve pain and nausea, as well as anecdotally or in restricted research to treat glaucoma, epilepsy, and anxiety, among other disorders and symptoms. Businesses have finally caught on, and it could not have come at a better time.
Producers can now isolate the two key chemical compounds present in marijuana: THC (Tetrahydrocannabinol) and CBD (Cannabidiol), thanks to modern science. THC has medical benefits, but it is better known as the psychoactive ingredient of marijuana. This is due to the fact that it is a synthetic drug. On the other hand, CBD is non-psychoactive, meaning it can (allegedly) have many of the plant's anti-anxiety and analgesic effects without causing a high. This, understandably, gives marijuana a fresh appeal. It is now possible to enjoy the plant's benefits without being intoxicated, helping to alleviate anxiety and pain while remaining functional.
Many of the health benefits of CBD and cannabis, in general, have yet to be demonstrated in statistically relevant, peer-reviewed research. This is due to various factors, the most important of which is that marijuana is still listed as a Schedule 1 controlled substance under federal law in the United States, making legality a problem in the research.
Alternatively, CBD and other cannabis items make up for their lack of evidence with enthusiasm. Companies and customers alike are keen to explore CBD in a range of things, ranging from food to oils to skincare, in the hopes of alleviating anxiety, insomnia, and other ailments. One must have probably seen CBD products worldwide if they live in a state where they are legal. According to one news media firm, CBD revenues are expected to increase 40-fold in the next four years, hitting a value of $23 billion. Marijuana and CBD are big businesses, and one pharmaceutical in California is one of the world's largest publicly traded cannabis firms.